This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (20)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Choroidal Neovascularization  • Retinal/ Chorioretinal Disorders  • Immunology  • Immunology, Other  • Alert me on articles by topic  Social Bookmarking   What's this?

Chrisjan Dees, FRCS; Jennifer J. Arnold, FRACO; John V. Forrester, MD; Andrew D. Dick, MD

Arch Ophthalmol. 1998;116:1456-1461.

Objective  To determine whether resolution of choroidal neovascularization (CNV), a recognized sight-threatening complication of endogenous posterior uveitis, and maintenance of vision could be achieved with immunosuppression.

Patients and Methods  Fourteen patients (17 eyes) with CNV associated with endogenous posterior uveitis were enrolled in an open study. Ages ranged from 5 to 51 years. Three eyes had extrafoveal CNV, 6 juxtafoveal, and 8 subfoveal. Three patients were treated with a single course of oral corticosteroids, 2 had additional cyclosporine for up to 2 years, and 9 continued to receive a low-dose regimen of a combination of immunosuppressive drugs.

Results  After a median follow-up of 15 months (range, 7 months to 6 years), 9 of 17 eyes had an improvement in visual acuity; 6 remained within 1 Snellen line of initial visual acuity, and 2 had lost 2 Snellen lines. Angiographically, CNV resolved in 13 eyes, resolved then recurred in 3, and improved but persisted in 4.

Conclusion  These results support a role for immunosuppressive therapy in the treatment of CNV associated with endogenous posterior uveitis.

From the Eye Department, Aberdeen Royal Infirmary (Drs Dees and Arnold) and the Department of Ophthalmology, University of Aberdeen (Drs Forrester and Dick), Aberdeen, Scotland.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Uveitic Foveal Atrophy: Clinical Features and Associations
Forooghian et al.
Arch Ophthalmol 2009;127:179-186.
ABSTRACT | FULL TEXT  

Two-year results of surgical removal of choroidal neovascular membranes related to non-age-related macular degeneration
Essex et al.
Br J Ophthalmol 2007;91:649-654.
ABSTRACT | FULL TEXT  

Outcomes after combination photodynamic therapy and immunosuppression for inflammatory subfoveal choroidal neovascularisation
Hogan et al.
Br J Ophthalmol 2005;89:1109-1111.
ABSTRACT | FULL TEXT  

Cyclosporine vs Tacrolimus Therapy for Posterior and Intermediate Uveitis
Murphy et al.
Arch Ophthalmol 2005;123:634-641.
ABSTRACT | FULL TEXT  

Photodynamic therapy for inflammatory choroidal neovascularisation unresponsive to immunosuppression
Leslie et al.
Br J Ophthalmol 2005;89:147-150.
ABSTRACT | FULL TEXT  

Serpiginous choroidopathy presenting as choroidal neovascularisation
Lee et al.
Br J Ophthalmol 2003;87:1184-1185.
FULL TEXT  

CXCR4 Receptor Expression on Human Retinal Pigment Epithelial Cells from the Blood-Retina Barrier Leads to Chemokine Secretion and Migration in Response to Stromal Cell-Derived Factor 1{alpha}
Crane et al.
J. Immunol. 2000;165:4372-4378.
ABSTRACT | FULL TEXT  

Early treatment with cyclosporin in serpiginous choroidopathy maintains remission and good visual outcome
Araujo et al.
Br J Ophthalmol 2000;84:979-982.
ABSTRACT | FULL TEXT  

Ocular involvement in sarcoidosis
ROTHOVA
Br J Ophthalmol 2000;84:110-116.
FULL TEXT